Natural peptides to drugs - fourth international congress
Affiliations
- PMID: 20506056
Item in Clipboard
Natural peptides to drugs - fourth international congress
IDrugs.
2010 Jun.
Abstract
The Natural Peptides to Drugs congress, held in Zermatt, Switzerland, included topics covering new therapeutic developments in the field of peptide- and protein-based drugs derived from natural products. This conference report highlights selected presentations on drug discovery from natural peptides, natural peptide-based drugs in preclinical and clinical development, and peptide candidates. Investigational drugs discussed include novel small peptides from KAI Pharmaceuticals Inc, XEP-018 (Atheris Laboratories), MKC-253 (MannKind Corp), AEZS-108 (AEterna Zentaris Inc) and XG-102 (Auris Medical AG/Xigen SA).
Similar articles
-
The role of natural products in drug discovery and development in the new millennium.IDrugs. 2010 Feb;13(2):70-2. IDrugs. 2010. PMID: 20127553
-
International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.IDrugs. 2010 Jan;13(1):23-5. IDrugs. 2010. PMID: 20024843
-
Terrapinn's world influenza congress Europe 2009. Part 2.IDrugs. 2010 Feb;13(2):78-9. IDrugs. 2010. PMID: 20127556
-
Uncovering the therapeutic potential of natural products with biomarker-guided screening.IDrugs. 2010 May;13(5):321-4. IDrugs. 2010. PMID: 20432189 Review.
-
Natural products in drug discovery: present status and perspectives.Adv Exp Med Biol. 2009;655:13-27. doi: 10.1007/978-1-4419-1132-2_2. Adv Exp Med Biol. 2009. PMID: 20047031 Review.